Skin formulation

Details Skin formulation Skin formulation

1985-03-04

1986-08-26

Ore, Dale R.

Drug, bio-affecting and body treating compositions

Designated organic active ingredient containing

Ortho-hydroxybenzoic acid or derivative doai

424DIG2, 424DIG4, 514163, 514557, 514848, 514859, 514864, A61K 748

Patent

active

046083707

ABSTRACT:
Skin treating composition comprising about 3 to about 7 parts salicylic acid, about 8 to 12 parts resorcinol, about 8 to about 12 parts lactic acid, and about 60 to about 90 parts ethyl alcohol, by weight. The composition is applied to the face, and after approximately a week, causes light peeling of dead surface skin together with removal at least some blemishes, imparting a youthful and healthy complexion.

REFERENCES:
patent: 2942008 (1960-06-01), Lubowe
patent: 3236730 (1966-02-01), Galin
patent: 3265571 (1966-08-01), Krezanoski
patent: 4147782 (1979-04-01), Klein et al.
patent: 4210654 (1980-07-01), Bauer et al.
patent: 4294852 (1981-10-01), Wildnauer et al.
patent: 4318907 (1982-03-01), Kligman et al.
Martindale, Extra Pharmacopoeia, 1958, vol. I, 24th edition, pp. 6 to 13, 1174 to 1183, 1278 and 1279.
Bennett, The Cosmetic Formulary, 1937, pp. 122, 233.

Affiliated with

Also associated with

Rating

Skin formulation does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Skin formulation, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Skin formulation will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-2312665